Views: 0 Author: Kevin Fang Publish Time: 2026-06-15 Origin: Chensheng Medical
Table of Contents
Sterilization method selection is one of the most consequential decisions in medical device development — and one that is frequently deferred too late in the design process.
By the time many device developers consider sterilization, the product geometry is locked, the packaging is designed, and the regulatory submission timeline is set. Discovering at that point that your chosen sterilization method is incompatible with your silicone compound, your packaging material, or your device assembly creates expensive redesign cycles and delays.
The right time to select your sterilization method is during initial product design — before tooling is cut, before packaging is specified, and before regulatory timelines are committed.
This guide gives you the complete technical framework to make that decision correctly for medical silicone products: tubing, molded components, catheters, drainage systems, respiratory circuits, and custom OEM assemblies.
Silicone is broadly compatible with all major sterilization methods — which is one of its key advantages over PVC, polyurethane, and latex. However, "broadly compatible" does not mean "equally compatible." Each sterilization method interacts with silicone in specific ways that affect:
Extractables and leachables profile — some methods introduce new chemical species into the silicone matrix
Mechanical properties — repeated sterilization cycles can cause cumulative property changes
Biocompatibility — post-sterilization biocompatibility testing may be required
Dimensional stability — some methods cause temporary or permanent dimensional changes
Packaging requirements — each method requires specific packaging materials and configurations
Regulatory validation burden — validation requirements differ significantly by method
Understanding these interactions allows you to select the method that best fits your product, your manufacturing process, and your regulatory pathway.
Method | Mechanism | Temperature | Silicone Compatibility | Primary Standard | Typical Use Case |
Steam Autoclave | Moist heat / pressure | 121°C or 134°C | ✅ Excellent | ISO 17665 | Reusable devices, hospital reprocessing |
Ethylene Oxide (EtO) | Alkylating gas | 37–63°C | ✅ Excellent | ISO 11135 | Single-use devices, heat-sensitive assemblies |
Gamma Irradiation | Ionizing radiation (Co-60) | Ambient | ✅ Good | ISO 11137 | Single-use, high-volume production |
Electron Beam (E-Beam) | Ionizing radiation (electrons) | Ambient | ✅ Good | ISO 11137 | Single-use, high-volume, faster cycle |
VHP / H₂O₂ Plasma | Vaporized hydrogen peroxide | 30–50°C | ✅ Good | ISO 22441 | Heat-sensitive, electronics-containing assemblies |
Each method is examined in detail below.
Steam autoclave sterilization uses saturated steam under pressure to achieve sterilization through moist heat. The two standard cycles are:
121°C / 15 psi / 15–30 minutes — standard gravity cycle (ISO 17665 Class B)
134°C / 30 psi / 3–18 minutes — pre-vacuum cycle (flash sterilization, prion protocols)
Sterilization is achieved by the denaturation of microbial proteins and disruption of cell membranes. The combination of heat, moisture, and pressure is highly effective against all vegetative bacteria, spores, viruses, and fungi.
Platinum-cured medical silicone is exceptionally well-suited to steam autoclave sterilization. The silicone backbone (Si–O–Si) is thermally stable to well above 200°C, and the platinum catalyst system produces no degradation products under autoclave conditions.
Cycle durability for platinum-cured silicone:
121°C cycles: 200+ cycles with no significant property change
134°C cycles: 100+ cycles with minimal property change (<5% tensile strength reduction)
Shore A hardness change after 100 cycles at 134°C: typically < 3 Shore A units
Dimensional change after repeated cycling: < 0.5% for well-formulated compounds
Peroxide-cured silicone caution: Peroxide-cured silicone shows greater property degradation under repeated autoclave cycling — particularly compression set increase and surface tackiness development. This is another reason platinum-cured compounds are the standard for reusable medical silicone products. See: Platinum-Cured vs. Peroxide-Cured Silicone: Which Is Better for Your Application?
Steam autoclave requires steam-permeable packaging that allows steam penetration while maintaining sterile barrier integrity after the cycle:
Peel pouches: Paper/film laminates (Tyvek/film or paper/film) — standard for wrapped single items
Sterilization wrap: Non-woven polypropylene — for wrapped trays and instrument sets
Rigid sterilization containers: Stainless steel or anodized aluminum with filter vents
NOT compatible: Sealed foil pouches, sealed PE bags, any non-breathable packaging
Packaging must be validated per ISO 11607-1 (sterile barrier system requirements) and ISO 11607-2 (validation of forming, sealing, and assembly processes).
ISO 17665-1:2006 — Sterilization of health care products: Moist heat
Key validation elements:
Installation Qualification (IQ): Autoclave equipment qualification
Operational Qualification (OQ): Empty chamber heat distribution mapping
Performance Qualification (PQ): Loaded chamber heat penetration studies with biological indicators (Geobacillus stearothermophilus, D-value ≥ 1.5 min at 121°C)
Sterility Assurance Level (SAL): 10−610−6 (one in one million probability of a non-sterile unit)
Advantages | Limitations |
No chemical residuals — no post-sterilization aeration required | Not suitable for moisture-sensitive components or electronics |
Fastest cycle time (15–30 min) | Requires steam-permeable packaging — limits packaging options |
Lowest cost per cycle for reusable devices | Repeated cycling causes cumulative (though minimal) property changes |
Validated for reusable devices — supports multiple-use labeling | Not suitable for sealed, non-breathable device assemblies |
No radiation effects on materials | High temperature excludes heat-sensitive device components |
Universally available in hospital settings | Wet packaging risk if drying cycle is inadequate |
Reusable medical silicone products: respiratory circuit components for hospital reprocessing, reusable drainage systems, silicone components in reusable surgical instruments, laboratory silicone tubing.
EtO sterilization uses ethylene oxide gas — a highly reactive alkylating agent — to sterilize by chemically modifying DNA and proteins in microorganisms, preventing replication. The process occurs at low temperature (37–63°C) under controlled humidity and EtO concentration conditions.
A standard EtO cycle consists of four phases:
Pre-conditioning: Humidity and temperature equilibration (typically 24–48 hours)
Gas exposure: EtO concentration 450–1,200 mg/L, 1–6 hours exposure
Evacuation: Gas removal from chamber
Aeration: Residual EtO and by-products (ethylene glycol, ethylene chlorohydrin) dissipate from product — typically 12–48 hours at 50–60°C
EtO is fully compatible with platinum-cured medical silicone. Silicone does not react with EtO, and the gas penetrates silicone matrices readily, ensuring complete sterilization of lumens and complex geometries.
Key consideration: EtO residuals in silicone
Silicone absorbs EtO during the sterilization cycle. The aeration phase is critical to reduce residuals to safe levels. Regulatory limits for EtO residuals in medical devices are defined in ISO 10993-7:2008:
Residual | Limit (short-term/limited contact) | Limit (prolonged contact) | Limit (permanent contact) |
Ethylene oxide (EtO) | 20 mg/device | 2 mg/device | 0.5 mg/device |
Ethylene chlorohydrin (ECH) | 12 mg/device | 2 mg/device | 0.5 mg/device |
Ethylene glycol (EG) | 200 mg/device | 40 mg/device | 10 mg/device |
Silicone tubing with large surface area or thick walls requires longer aeration times to achieve these limits. Your EtO sterilization partner must validate aeration time specifically for your product geometry and packaging configuration.
EtO requires gas-permeable packaging to allow EtO penetration and residual gas evacuation:
Tyvek/film peel pouches: The industry standard — Tyvek (spunbonded polyethylene) is highly EtO-permeable while maintaining sterile barrier
Paper/film laminates: Acceptable for many applications
Tyvek lidded trays: For complex device assemblies
NOT compatible: Foil laminates, sealed PE bags, any packaging that blocks gas permeation
Critical packaging design rule: The Tyvek or paper side must face the product and be accessible to gas flow. Packaging geometry must allow complete gas penetration to all product surfaces, including tubing lumens.
ISO 11135:2014 — Sterilization of health care products: Ethylene oxide
Key validation elements:
Microbiological qualification: Bioburden determination + biological indicator (Bacillus atrophaeus, ATCC 9372) studies
Physical/chemical qualification: EtO concentration, humidity, temperature, and time parameter validation
Residuals testing: Per ISO 10993-7 for all contact categories
Half-cycle and full-cycle overkill studies or fraction negative studies
SAL: 10−610−6
Advantages | Limitations |
Low temperature — compatible with heat-sensitive device components | Longest total cycle time (pre-conditioning + exposure + aeration: 2–5 days) |
Excellent penetration of complex geometries and tubing lumens | EtO is toxic, carcinogenic — requires specialized facility and environmental controls |
No radiation effects on silicone properties | Residuals testing required per ISO 10993-7 |
Industry standard for single-use medical devices | Higher cost per cycle than autoclave or gamma for high volumes |
Compatible with a wide range of packaging materials | Increasing regulatory scrutiny of EtO emissions (EPA, EU) |
Validated for complex assemblies with multiple materials | Requires validated aeration — cannot ship immediately after sterilization |
Single-use medical silicone products supplied sterile: catheters, drainage systems, respiratory circuits, IV tubing assemblies, complex multi-component device kits. EtO is the most widely used sterilization method for single-use medical silicone products globally.
At Chensheng Medical, EtO sterilization is our standard offering for sterile single-use silicone products. We work with validated contract sterilization partners and provide full ISO 10993-7 residuals documentation with every sterile product shipment.
Gamma irradiation uses high-energy photons emitted by Cobalt-60 (Co-60) radioactive sources to sterilize by ionizing radiation. The radiation damages microbial DNA, preventing replication. The process occurs at ambient temperature with no chemical agents involved.
Sterilization dose is measured in kilograys (kGy). Standard sterilization doses for medical devices:
Minimum sterilization dose: 15–25 kGy (validated per ISO 11137-2)
Standard dose: 25 kGy (most common — provides SAL 10−610−6 for typical bioburden levels)
High dose: 50 kGy (for high-bioburden products or additional safety margin)
Platinum-cured silicone is compatible with gamma irradiation at standard sterilization doses, but with some important nuances:
Effects of gamma irradiation on platinum-cured silicone:
Property | Change at 25 kGy | Change at 50 kGy | Notes |
Shore A hardness | +2 to +5 units | +5 to +10 units | Additional crosslinking; slight stiffening |
Tensile strength | ±5% | -5 to -10% | Generally within acceptable range |
Elongation at break | -5 to -10% | -10 to -20% | Slight reduction; verify for dynamic applications |
Compression set | +2 to +5% | +5 to +10% | Relevant for pump tubing applications |
Color | Slight yellowing | Moderate yellowing | Cosmetic; clears over weeks post-irradiation |
Transparency | Slight reduction | Moderate reduction | Temporary; recovers partially over time |
Extractables | Minimal change | Minimal change | Key advantage over EtO |
Important: The slight hardening and yellowing effects of gamma irradiation are temporary and largely reversible — they diminish significantly over 2–8 weeks post-irradiation as free radicals recombine. For critical applications (pump tubing, precision dimensional components), test samples after the full post-irradiation recovery period before finalizing specifications.
Dose mapping is critical: The dose received by different parts of a product load varies depending on product density, packaging configuration, and position in the irradiator. Dose mapping studies must confirm that the minimum sterilization dose is achieved throughout the load while the maximum dose does not exceed the product's material tolerance.
Gamma irradiation is compatible with most packaging materials, including:
Tyvek/film peel pouches ✅
Foil laminates ✅ (unlike EtO — a key advantage)
Sealed PE/PP bags ✅
Rigid plastic trays with lidding film ✅
Paperboard cartons ✅
Packaging materials to verify: Some polymers (PVC, certain nylons) degrade under gamma irradiation. For silicone products in mixed-material assemblies, verify all components for gamma compatibility.
ISO 11137-1:2006 — Sterilization of health care products: Radiation (Requirements for development, validation, and routine control)ISO 11137-2:2013 — Establishing the sterilization doseISO 11137-3:2017 — Guidance on dosimetric aspects
Key validation elements:
Bioburden determination: Per ISO 11737-1
Dose setting: Method 1 (VDmax), Method 2 (incremental dose experiment), or Substantiation
Dose audit: Quarterly bioburden monitoring to confirm dose remains valid
Dosimetry system: Calibrated dosimeters placed throughout the product load
Advantages | Limitations |
No chemical residuals — no aeration required | Causes slight, temporary hardening and yellowing of silicone |
Fast cycle — product can ship same day as irradiation | Requires Co-60 irradiation facility — not available in-house for most manufacturers |
Compatible with sealed, non-breathable packaging | Dose uniformity challenges for dense or irregular product loads |
Highly consistent and reproducible | Cumulative dose effects with repeated irradiation |
Excellent penetration — effective for high-density loads | Some materials (PVC, certain adhesives) are incompatible |
No temperature or humidity requirements | Regulatory dose audit requirements add ongoing validation burden |
High-volume single-use silicone products where fast turnaround is important: IV tubing, drainage bags, catheter kits, respiratory circuit components. Gamma is particularly advantageous when sealed packaging (foil or PE) is required, or when EtO residuals are a concern for the specific application.
E-beam sterilization uses accelerated electrons from an electron accelerator (linear accelerator or Van de Graaff generator) rather than gamma photons. The sterilization mechanism is identical to gamma — ionizing radiation damages microbial DNA — but the delivery method differs fundamentally:
Parameter | Gamma (Co-60) | E-Beam |
Radiation source | Radioactive isotope (Co-60) | Electrical accelerator |
Penetration depth | Deep (30–40 cm in water) | Shallow (5–8 cm in water at 10 MeV) |
Dose rate | Low (1–10 kGy/hour) | Very high (10–100 kGy/second) |
Cycle time | Hours | Seconds to minutes |
Facility type | Fixed irradiator | Fixed or mobile accelerator |
Regulatory source | Radioactive material license | Electrical equipment |
E-beam effects on platinum-cured silicone are similar to gamma irradiation at equivalent doses, with one important difference: the very high dose rate of e-beam can cause more pronounced free radical generation in a shorter time, potentially leading to slightly greater immediate property changes that recover more quickly.
In practice, for standard medical silicone tubing and molded components at 25–50 kGy, e-beam and gamma produce equivalent sterilization outcomes with comparable material effects.
Key limitation of e-beam: penetration depth. E-beam electrons have limited penetration compared to gamma photons. At 10 MeV (a common accelerator energy), the practical penetration depth in water-equivalent material is approximately 5–8 cm. This means:
Product density and packaging configuration must be carefully controlled
Dense or thick products may receive insufficient dose at the center
Double-sided irradiation is often required for thicker product configurations
For thin-wall silicone tubing and flat-packed single-use products, e-beam penetration is generally adequate. For dense molded components or thick-walled assemblies, gamma irradiation provides more uniform dose distribution.
ISO 11137-1, -2, -3 — same standards as gamma irradiation (both are radiation sterilization methods)
Advantages | Limitations |
Fastest cycle — seconds to minutes vs. hours for gamma | Limited penetration depth — not suitable for dense or thick products |
No radioactive material — no isotope storage or disposal | Requires specialized accelerator facility |
Can be turned off — no ongoing radiation hazard | Higher capital cost than gamma facilities |
Similar material compatibility to gamma | Less widely available than gamma irradiation services |
No chemical residuals | Dose uniformity more challenging for complex geometries |
Compatible with sealed packaging | Double-sided irradiation often required |
Thin, flat, or low-density single-use silicone products where rapid turnaround is critical: single-use tubing sets, thin-wall catheters, flat-packed drainage components, IV tubing. E-beam is increasingly used for high-volume, thin-profile medical silicone products where the speed advantage justifies the facility investment.
VHP sterilization uses vaporized hydrogen peroxide (H₂O₂) — typically at concentrations of 30–35% — as the sterilizing agent. The vapor penetrates packaging and product surfaces, oxidizing microbial proteins and cell membranes. The process operates at low temperature (30–50°C) and leaves no toxic residuals — H₂O₂ decomposes to water and oxygen.
Two main variants:
VHP (Vaporized H₂O₂): Gas-phase H₂O₂ in a sealed chamber — used for room and equipment decontamination as well as some device sterilization
H₂O₂ Plasma (STERRAD®-type): H₂O₂ vapor followed by plasma phase — used in hospital point-of-care sterilizers
Platinum-cured silicone is compatible with VHP/H₂O₂ plasma sterilization. H₂O₂ does not react with the silicone backbone, and the low temperature prevents thermal effects.
Practical limitations for silicone products:
VHP has limited penetration into long, narrow lumens — tubing with ID < 3mm and length > 500mm may not achieve adequate sterilization at the lumen interior
Cellulose-based materials (paper, some packaging) absorb H₂O₂ and are incompatible — limits packaging options
Not validated for high-bioburden products — VHP is most effective for low-bioburden, clean device surfaces
VHP requires H₂O₂-permeable packaging:
Tyvek/film peel pouches ✅ (Tyvek is permeable to H₂O₂ vapor)
Non-woven polypropylene wrap ✅
NOT compatible: Paper-based packaging (absorbs H₂O₂), foil laminates, sealed PE bags
ISO 22441:2022 — Sterilization of health care products: Low temperature vaporized hydrogen peroxide
Silicone components in complex device assemblies containing electronics, batteries, or other heat-sensitive elements that cannot withstand EtO or autoclave. Also used for terminal sterilization of silicone components in robotic surgical systems and advanced diagnostic devices.
Criterion | Autoclave | EtO | Gamma | E-Beam | VHP |
Silicone compatibility | ✅ Excellent | ✅ Excellent | ✅ Good | ✅ Good | ✅ Good |
Temperature | 121–134°C | 37–63°C | Ambient | Ambient | 30–50°C |
Chemical residuals | None | Yes (requires aeration) | None | None | None (decomposes) |
Radiation effects | None | None | Slight hardening/yellowing | Slight hardening/yellowing | None |
Cycle time (total) | 15–60 min | 2–5 days | 4–8 hours | Minutes | 1–3 hours |
Penetration | Excellent | Excellent | Excellent | Limited (5–8cm) | Limited (narrow lumens) |
Packaging flexibility | Steam-permeable only | Gas-permeable only | Most materials | Most materials | H₂O₂-permeable only |
Sealed packaging | ❌ No | ❌ No | ✅ Yes | ✅ Yes | ❌ No |
Reusable device support | ✅ Yes | ❌ No | ❌ No | ❌ No | ✅ Limited |
Validation standard | ISO 17665 | ISO 11135 | ISO 11137 | ISO 11137 | ISO 22441 |
Relative cost (per unit) | Lowest | Medium | Low–medium | Low–medium | High |
Availability | Universal | Specialized | Specialized | Specialized | Hospital/specialized |
Regulatory complexity | Low | High (residuals) | Medium | Medium | Medium |
Best application | Reusable devices | Single-use, complex assemblies | High-volume single-use | Thin, flat single-use | Electronics-containing |
A critical point that is frequently overlooked: sterilization can change the biocompatibility profile of a medical silicone product. ISO 10993-1:2018 (the FDA-recognized biocompatibility evaluation framework) explicitly requires that biocompatibility testing be conducted on product in its final sterilized state — not on unsterilized material.
Method | Potential Biocompatibility Impact | ISO 10993 Consideration |
Autoclave | Minimal — no new chemical species introduced | Standard biocompatibility testing on autoclaved samples is sufficient |
EtO | EtO residuals (EtO, ECH, EG) are cytotoxic and mutagenic | ISO 10993-7 residuals testing mandatory; cytotoxicity testing on aerated product |
Gamma | Free radical generation may increase extractables transiently | Test after post-irradiation recovery period (2–4 weeks); extractables may be elevated immediately post-irradiation |
E-Beam | Similar to gamma — transient free radical effects | Same approach as gamma; test after recovery period |
VHP | H₂O₂ residuals possible in absorbed materials | Verify H₂O₂ residuals on silicone surface; generally minimal for silicone |
Practical implication: If you change your sterilization method after completing biocompatibility testing, you must re-evaluate biocompatibility on the product sterilized by the new method. This is a regulatory requirement, not a recommendation.
For a complete overview of biocompatibility testing requirements for medical silicone, see: USP Class VI, ISO 10993, and FDA 21 CFR 177.2600: Which Certification Do You Actually Need?
Use this framework to narrow your sterilization method selection based on your product characteristics:
Reusable → Autoclave is the primary option (hospital reprocessing infrastructure)
Single-use → Continue to Step 2
Yes (electronics, batteries, certain adhesives, heat-sensitive polymers) → EtO or VHP
No → Continue to Step 3
Yes → EtO (best lumen penetration) or Autoclave
No → Continue to Step 4
Sealed foil or PE packaging required → Gamma or E-Beam
Tyvek/breathable packaging acceptable → EtO, Gamma, or E-Beam
High volume, fast turnaround → Gamma or E-Beam
Lower volume, complex assembly → EtO
Hospital point-of-care reprocessing → Autoclave
Drug contact, pharmaceutical manufacturing, neonatal applications → Gamma or E-Beam preferred (no residuals)
Standard medical device applications → EtO acceptable with validated aeration
When sourcing medical silicone products from Chensheng Medical or any other supplier, the following sterilization-related documentation should be requested and verified:
✅ EtO sterilization validation report (ISO 11135)
✅ ISO 10993-7 residuals test report (EtO, ECH, EG — lot-specific or periodic)
✅ Aeration validation data (time and temperature)
✅ Biological indicator results (BIs) for each sterilization run
✅ Packaging validation per ISO 11607
✅ Irradiation validation report (ISO 11137-1, -2)
✅ Dose mapping study results
✅ Dosimetry records for each production lot
✅ Bioburden monitoring records (quarterly dose audit)
✅ Post-irradiation material property data (Shore A, tensile, compression set)
✅ Autoclave validation report (ISO 17665)
✅ Cycle parameter records (temperature, pressure, time) for each lot
✅ Biological indicator results
✅ Packaging validation per ISO 11607
✅ Biocompatibility testing conducted on sterilized product (ISO 10993-1)
✅ Shelf life validation (accelerated aging per ASTM F1980 + real-time aging)
✅ Sterility test results per ISO 11737-2 (if required by regulatory pathway)
For guidance on evaluating whether a supplier can provide this documentation, and how to verify its authenticity, see: How to Choose a Reliable Medical Silicone Manufacturer in China
For reusable medical silicone products — respiratory circuits, reusable drainage components, silicone components in reusable surgical instruments — the cumulative effect of repeated sterilization cycles must be validated.
The standard approach for validating reusable silicone products for autoclave reprocessing:
Determine the intended use life — how many sterilization cycles is the device intended to withstand? (Typical: 50, 100, or 200 cycles)
Conduct accelerated cycling — subject test samples to the full intended number of cycles plus a safety margin (typically 125% of intended cycles)
Measure properties at defined intervals — Shore A hardness, tensile strength, elongation, compression set, dimensional measurements at 0, 25, 50, 75, 100, and 200 cycles
Establish acceptance criteria — define the maximum acceptable property change that still meets functional requirements
Document and include in regulatory submission — cycle durability data is required for reusable device submissions (510(k), CE Technical File)
Typical acceptance criteria for reusable silicone respiratory circuit tubing:
Shore A hardness change: ≤ 5 Shore A units after 100 cycles at 134°C
Tensile strength retention: ≥ 80% of initial value
Elongation at break retention: ≥ 75% of initial value
No visible surface cracking, tackiness, or discoloration
Dimensional change: ≤ 1% on critical dimensions
For respiratory circuit-specific compliance requirements including reprocessing validation, see: Medical-Grade Silicone Tubing for Respiratory Circuits: Compliance Requirements
Q1: Which sterilization method is best for medical silicone tubing?
A: There is no single "best" method — the optimal choice depends on your application, device design, packaging requirements, and production volume. For single-use silicone products supplied sterile, EtO is the most widely used method due to its excellent penetration and compatibility with complex assemblies. Gamma irradiation is preferred for high-volume products where sealed packaging is required or EtO residuals are a concern. For reusable silicone products reprocessed in hospital settings, steam autoclave is the standard. Use the decision framework in this article to identify the right method for your specific product.
Q2: Can I sterilize medical silicone tubing multiple times using gamma irradiation?
A: Gamma irradiation is a terminal sterilization method intended for single-use products — it is not designed for repeated reprocessing cycles. Each irradiation dose causes cumulative crosslinking and property changes in silicone. For products requiring multiple sterilization cycles, steam autoclave is the appropriate method. If you have a specific application requiring repeated gamma sterilization, contact our applications engineering team to discuss the feasibility and required validation approach.
Q3: How long does EtO aeration take for silicone tubing, and can it be accelerated?
A: Aeration time depends on product geometry (wall thickness, lumen diameter, length), packaging configuration, and aeration temperature. Typical aeration times for medical silicone tubing range from 12 hours (thin-wall, small-bore tubing at 60°C) to 48 hours (thick-wall, large-bore tubing at 50°C). Aeration can be accelerated by increasing temperature (up to 60°C for silicone) and improving air circulation. The aeration time must be validated per ISO 10993-7 for your specific product — the validated time cannot be shortened without re-validation.
Q4: Does gamma irradiation affect the USP Class VI or ISO 10993 compliance of silicone tubing?
A: Biocompatibility testing must be conducted on product in its final sterilized state (ISO 10993-1 requirement). If your silicone tubing has USP Class VI and ISO 10993 test reports conducted on unsterilized or EtO-sterilized material, those reports do not automatically cover gamma-irradiated product. You should request biocompatibility test reports conducted on gamma-irradiated samples, or conduct additional testing on irradiated samples. At Chensheng Medical, we provide biocompatibility documentation specific to the sterilization method used for your product.
Q5: Can the same silicone tubing specification be used for both EtO and gamma sterilization?
A: In most cases, yes — platinum-cured medical silicone is compatible with both methods. However, you should verify: (1) that biocompatibility testing has been conducted on samples sterilized by both methods; (2) that post-gamma property changes (slight hardening, yellowing) are acceptable for your application; (3) that your packaging is compatible with both methods (Tyvek/film pouches work for both EtO and gamma; sealed foil works for gamma but not EtO). Dual-method validation adds regulatory burden but provides supply chain flexibility.
Q6: What is the shelf life of EtO-sterilized silicone tubing, and how is it validated?
A: Shelf life for sterile medical silicone products is typically 2–5 years, depending on the product and packaging. Shelf life is validated by a combination of accelerated aging (per ASTM F1980 — elevated temperature storage to simulate real-time aging) and real-time aging (actual storage at defined conditions). The validation must demonstrate that the sterile barrier integrity is maintained throughout the claimed shelf life. At Chensheng Medical, our standard EtO-sterilized products carry a 2-year shelf life supported by validated accelerated aging data. Extended shelf life (3–5 years) is available for OEM products with specific validation requirements.
Q7: We are switching from EtO to gamma sterilization for an existing product. What regulatory steps are required?
A: Changing sterilization method for an existing medical device is a significant design change that requires: (1) new sterilization validation per ISO 11137 for gamma; (2) biocompatibility re-evaluation on gamma-sterilized product per ISO 10993-1; (3) packaging re-validation for gamma compatibility per ISO 11607; (4) shelf life re-validation if packaging changes; (5) regulatory submission of the change — a 510(k) supplement (US), Technical Documentation update (EU MDR), or equivalent depending on your market and device classification. Our applications engineering team can support the technical aspects of this transition. For regulatory strategy, we recommend consulting a regulatory affairs specialist for your specific market.
At Jinan Chensheng Medical Technology Co., Ltd., we support customers through the complete sterilization qualification process:
EtO sterilization: Available through our validated contract sterilization partners. Full ISO 10993-7 residuals documentation provided with every sterile lot.
Gamma irradiation: Available through our validated irradiation partners. Post-irradiation material property data and dosimetry records provided.
Autoclave validation support: We provide multi-cycle autoclave durability data for all reusable silicone products, supporting your reprocessing validation.
Biocompatibility documentation: All biocompatibility testing (USP Class VI, ISO 10993) is conducted on product in its final sterilized state, ensuring regulatory compliance.
Packaging design: We can advise on packaging material selection and configuration for your chosen sterilization method.
Whether you are selecting a sterilization method for a new product or re-validating an existing product for a new method, our team is available to provide technical guidance at no charge as part of our standard pre-sales support.
→ Contact Our Applications Engineering Team→ Browse Our Medical Silicone Tubing Range→ Request Sterilization Documentation for Your Application
Related Articles:
Platinum-Cured vs. Peroxide-Cured Silicone: Which Is Better for Your Application?
USP Class VI, ISO 10993, and FDA 21 CFR 177.2600: Which Certification Do You Actually Need?
Medical-Grade Silicone Tubing for Respiratory Circuits: Compliance Requirements
How to Choose a Reliable Medical Silicone Manufacturer in China
Silicone Shore A Hardness Explained: How to Select the Right Durometer for Your Medical Application
How to Choose Medical Grade Silicone Tubing: A Complete Specification and Sourcing Guide
How to Sterilize Medical Silicone Tubing: Autoclave, EO, and Gamma Compatibility Guide
How to Choose a Medical Silicone Tubing Supplier for Pharmaceutical Manufacturing
How to Conduct a Remote Factory Audit of a Chinese Medical Silicone Manufacturer (2026 Checklist)
Silicone Drainage Tubes and Closed Wound Drainage Systems: Clinical Requirements and Sourcing Guide
How to Conduct a Remote Factory Audit of a Chinese Medical Silicone Manufacturer
Medical Silicone Supply Chain Risk Management: How to Build a Resilient Sourcing Strategy
Sterilization Methods for Medical Silicone Products: Autoclave, EtO, Gamma, and E-Beam Compared
Silicone Shore A Hardness Explained: How to Select the Right Durometer for Your Medical Application
Peristaltic Pump Tubing Selection: Material Properties, Performance Factors, and How to Get It Right
Copyright © 2025 JINAN CHENSHENG MEDICAL TECHNOLOGY CO., LTD. 鲁ICP备2021012053号-1 互联网药品信息服务资格证书 (鲁)-非经营性-2021-0178 中文站
